Results 11 to 20 of about 1,206,208 (293)

Antibiotic therapy for bacterial pneumonia

open access: yesJournal of Pharmaceutical Health Care and Sciences
Pneumonia is a common infection in patients of all ages. Determining its etiology and selecting antibiotic therapy are challenging for physicians in both private practice and hospitals.
Hideo Kato
doaj   +2 more sources

Magneto-Sono-Enhanced Nanozyme Catalysis Drives ROS-Mediated Pathogen Killing and Mitophagy-Linked Inflammation Control in Bacterial Pneumonia. [PDF]

open access: yesAdv Sci (Weinh)
Nebulized BN@NF nanozymes integrate boron nanosheets with Nd‐doped iron phosphide to form a sono‐magneto‐responsive Z‐scheme heterostructure. Under ultrasound and magnetic activation, BN@NF amplifies ROS generation, eradicates bacteria, disrupts biofilms, and reshapes pulmonary inflammation through NF‐κB suppression, mitophagy promotion, and M1‐to‐M2 ...
Luo X   +6 more
europepmc   +2 more sources

Procalcitonin level comparison in HIV/AIDS patients between non-bacterial and bacterial pneumonia in East Indonesia [PDF]

open access: yes, 2021
Lower respiratory tract infections including pneumonia were the most common diseases diagnosed in HIV/AIDS patients. Bacteria, fungi, and viruses were pathogens that were often detected in pneumonia cases and required different management.
Yudhawati Meliana Resti, ,-   +4 more
core   +1 more source

Volatile diagnostic techniques for ventilator associated pneumonia [PDF]

open access: yes, 2010
Ventilator associated pneumonia (VAP) is a significant challenge for the Intensive Care doctors worldwide. It is both difficult to diagnose accurately and quickly and to treat effectively once the diagnosis has been established.
Humphreys, Martyn Lee
core   +7 more sources

Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study [PDF]

open access: yes, 2013
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do
Kunisaki, KM   +39 more
core   +1 more source

Bacterial Profile and Antibiotic Use in Pneumonia Patients at Dr. Soetomo General Hospital [PDF]

open access: yes, 2020
Background: Pneumonia is one of the causes of morbidity and mortality in children and adults worldwide. WHO report in 1999 stated that the main cause of death due to infectious disease is pneumonia.
Yulia, Rika   +3 more
core   +2 more sources

Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia : a prospective cohort study [PDF]

open access: yes, 2015
Diagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies.
Nimerta Rajwans   +43 more
core   +1 more source

Lung Ultrasound and Neutrophil Lymphocyte Ratio in Early Diagnosis and Differentiation between Viral and Bacterial Pneumonia in Young Children

open access: yesChildren, 2022
Lung ultrasound (LUS) is a crucial diagnostic tool for identifying pneumonia in the pediatric age group. However, it plays a limited role in the early distinction between viral and bacterial pneumonia in children.
Ahmed Omran   +5 more
doaj   +1 more source

Efficacy and safety of garenoxacin tablets on bacterial pneumonia: Postmarketing surveillance in Japan [PDF]

open access: yes, 2014
We performed a postmarketing surveillance study to determine the efficacy and safety of the oral quinolone antibacterial agent, garenoxacin (Geninax ® Tablets 200 mg), against bacterial pneumonia.
Watanabe, Akira   +6 more
core   +1 more source

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children

open access: yesBMC Pulmonary Medicine, 2019
Background Differentiating bacterial from viral pneumonia is important for guiding targeted management and judicious use of antibiotics. We assessed if clinical characteristics and blood inflammatory biomarkers could be used to distinguish bacterial from
Mejbah U. Bhuiyan   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy